Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 136

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 136
---
 December 31, 2024 
     500,000 

Warrants

In
connection with various transactions and the IPO summarized below, the Company issue stock warrants. Warrant activity for the year ended
December 31, 2024 is summarized below:

SCHEDULE
OF WARRANT ACTIVITY

    Weighted  

    Weighted  
    Average  

    Number
    of  
    Average
    Exercise  
    Remaining
    Contractual  
    Aggregate 

    Warrants  
    Price  
    Term
    (Years)  
    Intrinsic
    Value 
  
    Balance
    Outstanding as January 1, 2023 
     -  
    $-  
     -  
     - 
  
    Granted 
     1,763,570  
    $3.88  
     5.0  
        - 
  
    Balance
    Outstanding as December 31, 2023 
     1,763,570  
    $3.88  
     4.6  
     - 
  
    Granted 
     -  
    $-  
     -  
     - 
  
    Exercised 
     -  
    $-  
     -  
     - 
  
    Balance
    Outstanding as December 31, 2024 
     1,763,570  
    $3.88  
     3.6  
     - 
  
    Exercisable,
    December 31, 2024 
     1,763,570  
    $3.88  
     3.6  
     - 

MIRALOGX
warrants

The
Company issued to MIRALOGX a common stock purchase warrant on November 15, 2023 giving MIRALOGX the right to purchase up to 700,000 shares
of common stock at an exercise price of $2.00 per share. This warrant will expire five years after the date of grant.

The
fair value of the warrants were estimated on the grant date using the Black-Scholes valuation model and level 3 inputs based on assumptions
for expected volatility, expected dividends, expected term, and the risk-free interest rate, which resulted in $1.8 million of warrant
value. This cost was recorded in